No abstractEur J Nutr. 2026 Mar 17;65(3):98. doi: 10.1007/s00394-026-03904-0.NO ABSTRACTPMID:41843191 | DOI:10.1007/s00394-026-03904-0
No abstractEur J Nutr. 2026 Mar 17;65(3):99. doi: 10.1007/s00394-025-03877-6.NO ABSTRACTPMID:41843181 | DOI:10.1007/s00394-025-03877-6
Clin Res Cardiol. 2026 Mar 17. doi: 10.1007/s00392-026-02891-w. Online ahead of print.ABSTRACTBACKGROUND: Safety and efficacy have been well demonstrated for Micra™ leadless cardiac pacemakers (LCPs). However, the presence of sex-specific disparities remains unclear.METHODS: The aim of this single-c
Intensive Care Med. 2026 Mar 17. doi: 10.1007/s00134-026-08357-x. Online ahead of print.ABSTRACTINTRODUCTION: Renal replacement therapy (RRT) is a life-saving intervention in severe acute kidney injury (AKI). After a clinician-initiated discontinuation, the likelihood of sustained liberation remains
Hum Cell. 2026 Mar 17;39(4):54. doi: 10.1007/s13577-026-01357-5.ABSTRACTSmall-diameter vascular grafts remain a clinical challenge due to thrombosis, stenosis, and poor long-term patency of synthetic substitutes. Decellularised human amniotic membrane (dHAM), derived from placental tissue, offers a
Clin J Am Soc Nephrol. 2026 Mar 17. doi: 10.2215/CJN.0000001061. Online ahead of print.ABSTRACTProtein carbamylation is a non-enzymatic post-translational protein modification driven by urea-derived cyanate and its reactive form isocyanic acid. Because chronic kidney disease (CKD) is characterized i
JAMA Netw Open. 2026 Mar 2;9(3):e260937. doi: 10.1001/jamanetworkopen.2026.0937.ABSTRACTIMPORTANCE: Hypertension significantly increases the risk of cardiovascular diseases (CVDs) and related cardiometabolic conditions, yet the role of healthy lifestyle in modifying these risks remains underexplored
JACC Adv. 2026 Jan 6:102516. doi: 10.1016/j.jacadv.2025.102516. Online ahead of print.ABSTRACTBACKGROUND: Ultraprocessed foods (UPFs) have been linked to adverse cardiometabolic outcomes and increased atherosclerotic cardiovascular disease (CVD) (ASCVD) risk. However, prior research has largely focu
Endocr Pract. 2026 Mar 17:S1530-891X(26)00022-4. doi: 10.1016/j.eprac.2026.01.006. Online ahead of print.ABSTRACTOBJECTIVE: This consensus statement provides evidence-based visual guidance in graphic algorithms and a summary of evidence and considerations to assist health care professionals with the
Andes Pediatr. 2025 Dec;96(6):811-820. doi: 10.32641/andespediatr.v96i6.5763.ABSTRACTTrauma is a leading cause of mortality in the pediatric population. Approximately 50% of pediatric trauma deaths occur within the first 24 hours, with 30% considered preventable or potentially preventable. A signifi
Andes Pediatr. 2025 Aug;96(4):447-456. doi: 10.32641/andespediatr.v96i4.5361.ABSTRACTFollowing the initial months of the COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) was identified as an entity associated with SARS-CoV-2 infection. In addition to the viral epidemiological
Biomed Tech (Berl). 2026 Mar 17. doi: 10.1515/bmt-2026-0015. Online ahead of print.ABSTRACTOBJECTIVES: An effective automatic system for ventricular segmentation from MRI is vital for diagnosing cardiovascular diseases, yet challenges persist due to anatomical variations and artifacts.METHODS: We pr
Diabetes Care. 2026 Mar 17:dc252987. doi: 10.2337/dc25-2987. Online ahead of print.ABSTRACTOBJECTIVE: To investigate the association between "shrunken pore syndrome" (SPS), defined as a large discrepancy between estimated glomerular filtration rates based on cystatin C (eGFRcys) and creatinine (eGFR
Ann Am Thorac Soc. 2026 Mar 1;23(3):369-378. doi: 10.1093/annalsats/aaoaf039.ABSTRACTRATIONALE: Despite clear guideline recommendations, few patients with pulmonary hypertension (PH) are referred to -expert care, including high-risk patients with pulmonary arterial hypertension (PAH) and chronic thr
Arch Argent Pediatr. 2026 Mar 31;124(2):e202510766. doi: 10.5546/aap.2025-10766.eng.ABSTRACTIntroduction. Childhood overweight and obesity are known risk factors linked to the development of masked hypertension (MH). These factors may have a greater impact on ambulatory blood pressure (BP) than on o
Artif Cells Nanomed Biotechnol. 2026 Dec;54(1):245-263. doi: 10.1080/21691401.2026.2640825. Epub 2026 Mar 17.ABSTRACTThis research employs an integrated approach combining network pharmacology and molecular docking to assess the therapeutic potential of a Heat-Clearing and Dampness-Eliminating Formu
Radiology. 2026 Mar;318(3):e251586. doi: 10.1148/radiol.251586.ABSTRACTBackground Supracardiac atherosclerosis is a major cause of stroke. Although vessel wall MRI (vwMRI) can assess plaques, current techniques lack full head-neck-aortic arch coverage and efficiency. Purpose To develop and evaluate
Medicine (Baltimore). 2026 Mar 13;105(11):e48016. doi: 10.1097/MD.0000000000048016.ABSTRACTThis retrospective cohort study aims to examine the association between adherence to thiazolidinedione (TZD) therapy and the risk of all-cause mortality and cardiovascular (CV) outcomes in patients with type 2
J Clin Hypertens (Greenwich). 2026 Mar;28(3):e70230. doi: 10.1111/jch.70230.ABSTRACTThe goal of the TREAT study is to estimate the prevalence of true resistant hypertension in a Belgian setting of patients with apparent treatment resistant hypertension (aTRH) and to evaluate which determining factor
Appl Opt. 2025 Oct 1;64(28):8151-8160. doi: 10.1364/AO.562201.ABSTRACTIn this paper, we employed the Vision Transformer architecture to effectively classify diabetic retinopathy (DR) in retinal images. Our dataset consisted of validated images, categorized into two classes: "normal" and "abnormal."
Endokrynol Pol. 2026;77(1):5-10. doi: 10.5603/ep.108324.ABSTRACTBerardinelli-Seip syndrome, also known as congenital generalized lipodystrophy (CGL), is a rare genetic disorder characterized by lipoatrophy, acromegaloid features, hyperinsulinemia, hypertriglyceridemia, and hepatic steatosis. With es
Eur Heart J. 2026 Mar 17:ehag148. doi: 10.1093/eurheartj/ehag148. Online ahead of print.ABSTRACTOn the basis of seminal genetic discoveries, proprotein convertase subtilisin/kexin Type 9 (PCSK9) inhibitors were developed as a new class of LDL cholesterol-lowering drug, with a potency on par with and
Eur Heart J. 2026 Mar 17:ehag191. doi: 10.1093/eurheartj/ehag191. Online ahead of print.ABSTRACTBACKGROUND AND AIMS: Calcific aortic valve disease lacks effective pharmacotherapy and is tightly linked to ageing. Since nicotinamide adenine dinucleotide (NAD+) steadily declines with age, this study in
Eur J Heart Fail. 2026 Mar 17:xuag080. doi: 10.1093/ejhf/xuag080. Online ahead of print.ABSTRACTAIMS: Congestion signals heart failure progression and drives decompensation. Reliable management strategies remain poorly developed. We evaluated 12-months of congestion-guided clinical management follow
